Instil Bio (TIL) Non-Current Deferred Tax Liability (2020 - 2022)

Instil Bio has reported Non-Current Deferred Tax Liability for 3 years, with the latest figure at $1.5 million in Q4 2022.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 71.27% year-over-year to $1.5 million in Q4 2022; TTM through Dec 2022 was $1.5 million, a 71.27% decrease from a year earlier, with the FY2022 full-year figure at $1.5 million, down 71.27% from the prior year.
• Non-Current Deferred Tax Liability was $1.5 million for Q4 2022 at Instil Bio, up from $555000.0 in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $5.2 million in Q4 2021, with the low at $555000.0 in Q3 2022.
• Average Non-Current Deferred Tax Liability over 3 years is $2.1 million, with a median of $1.9 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2022: Non-Current Deferred Tax Liability surged 86.01% in 2021, then tumbled 71.27% in 2022.
• Over 3 years, Non-Current Deferred Tax Liability stood at $2.8 million in 2020, then soared by 86.01% to $5.2 million in 2021, then tumbled by 71.27% to $1.5 million in 2022.
• The last three Non-Current Deferred Tax Liability figures came in at $1.5 million (Q4 2022), $555000.0 (Q3 2022), and $1.1 million (Q2 2022), per Business Quant data.